Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.
about
Cytosolic prostaglandin E synthase: expression patterns in control and Alzheimer's disease brainsElevated microsomal prostaglandin-E synthase-1 in Alzheimer's diseaseMaximal COX-2 and ppRb expression in neurons occurs during early Braak stages prior to the maximal activation of astrocytes and microglia in Alzheimer's diseaseTargeting innate immunity for neurodegenerative disorders of the central nervous systemNon-steroidal anti-inflammatory drugs and cognitive function: are prostaglandins at the heart of cognitive impairment in dementia and delirium?Antagonism of neuronal prostaglandin E(2) receptor subtype 1 mitigates amyloid β neurotoxicity in vitroNO2 inhalation promotes Alzheimer's disease-like progression: cyclooxygenase-2-derived prostaglandin E2 modulation and monoacylglycerol lipase inhibition-targeted medicationCurcumin Ameliorates the Reduction Effect of PGE2 on Fibrillar β-Amyloid Peptide (1-42)-Induced Microglial Phagocytosis through the Inhibition of EP2-PKA Signaling in N9 Microglial CellsProstaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models.Cyclooxygenase-1 null mice show reduced neuroinflammation in response to beta-amyloid.A role for cyclooxygenase-1 in beta-amyloid-induced neuroinflammation.Microsomal prostaglandin E synthase-2: cellular distribution and expression in Alzheimer's disease.Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics.Prostaglandin E2 receptor subtype 2 regulation of scavenger receptor CD36 modulates microglial Aβ42 phagocytosis.Prostanoid signaling: dual role for prostaglandin E2 in neurotoxicity.Non-linear relationships of cerebrospinal fluid biomarker levels with cognitive function: an observational study.The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research.Inhibition of STAT3- and MAPK-dependent PGE2 synthesis ameliorates phagocytosis of fibrillar β-amyloid peptide (1-42) via EP2 receptor in EMF-stimulated N9 microglial cells.Inflammatory Eicosanoids Increase Amyloid Precursor Protein Expression via Activation of Multiple Neuronal Receptors.Inflammatory prostaglandin E2 signaling in a mouse model of Alzheimer disease.Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer's disease model mice.Mass spectrometric and computational analysis of cytokine-induced alterations in the astrocyte secretomeTherapeutic targets in prostaglandin E2 signaling for neurologic disease.The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer's DiseaseUntangling the Web: Toxic and Protective Effects of Neuroinflammation and PGE2 Signaling in Alzheimer's Disease.Inflammatory Cyclooxygenase Activity and PGE2 Signaling in Models of Alzheimer's DiseaseNeuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer's disease.Systemic and central immunity in Alzheimer's disease: therapeutic implications.Nitric oxide in neurodegeneration: potential benefits of non-steroidal anti-inflammatories.Therapeutic implications of disorders of cell death signalling: membranes, micro-environment, and eicosanoid and docosanoid metabolismPositive and negative effects of prostaglandins in Alzheimer's disease.Suppressed microglial E prostanoid receptor 1 signaling selectively reduces tumor necrosis factor alpha and interleukin 6 secretion from toll-like receptor 3 activation.Effects of a cyclooxygenase-2 preferential inhibitor in young healthy dogs exposed to air pollution: a pilot study.Cyclooxygenase (COX)-1 activity precedes the COX-2 induction in Aβ-induced neuroinflammation.Effect of PGE2-EPs pathway on primary cultured rat neuron injury caused by aluminum.Activation of EP2 receptor suppresses poly(I: C) and LPS-mediated inflammation in primary microglia and organotypic hippocampal slice cultures: Contributing role for MAPKs.CCAAT/enhancer binding protein β regulates prostaglandin E synthase expression and prostaglandin E2 production in activated microglial cells.The effects of two-stage carotid occlusion on spatial memory and pro-inflammatory markers in the hippocampus of rats.Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO
P2860
Q24632616-F9CC04E7-BEBE-4FF3-8C2C-9A9238678E04Q24647957-3B094815-72BB-4E16-B6D7-D1278AE11AEEQ24815590-A4424018-42C6-414F-884A-D445BBE97DFEQ26744219-E00C9E4D-94D4-48D4-A2CD-BFF5549BD190Q26822022-758F6BA5-B2B6-4E5E-954C-89680229AD57Q26861848-79BDA188-98DD-43EF-9CEB-9BE2A7B95458Q27334947-C8016C7F-7CF0-4633-B2F9-B4512B697DC3Q28552971-1A2C7A26-DB63-4C23-9985-6B27588E6ED3Q30634663-83087660-E3F4-4913-B7EB-74EF0F5BF433Q33588687-4E758A37-1D38-4653-BA89-9D25E8F8283BQ33588710-129B4986-50AF-4EDD-9313-424690ACC2FCQ33828792-3649F50B-4BDC-44BC-B9E3-7486F3A21433Q34735142-D294B752-66D4-44AF-801F-9A76ED6EC3DCQ34780834-F861F863-AD3E-463A-BE88-3B6290EE5F03Q34954633-B81BE598-963B-4281-8C86-3C6462A906AFQ35029099-15BAA98F-938D-49C2-BA76-C1EFE20A4B79Q36048230-56058088-077C-4F98-B98C-36ED4299D1B4Q36200280-84B25D50-06E1-49AD-A9B6-259028AA2B6CQ36379542-28B50EA2-6112-49E3-85D2-13DB523B7D0AQ36431280-90C7639D-5173-462E-B08C-2D5929FBAD89Q37081974-E4674E44-0C80-4819-8D63-7CAD7937E117Q37155916-D0FD9CA7-43C1-4184-AA2F-0943A33327F1Q37221356-652F909C-EDA0-4161-AA54-2F3286B6BFD1Q37261981-A6DB080A-77B5-451E-A236-85978F024D39Q37588183-7CF9AA5D-4CA8-4882-96A7-7CA67130E388Q37741526-F9DBCC30-9B95-4A4E-94E6-C655026AC1F3Q37783527-0D8225BC-6BAB-4CA2-9E5B-D7A400BDFF26Q37954456-B4570017-F6E6-414E-8CCE-20866612FB4BQ37959790-B41CF903-5B14-4BE2-A4BC-B1BDE21E654BQ37988008-1E37575D-A3DA-4F47-95EF-AD023AE373F3Q38132922-34F247F3-E3A9-4CBE-A0EF-9061A26907B6Q42116332-54E1154E-A818-40FE-829A-5AF1311D4B70Q45917440-00BA598E-9815-4D79-B872-A10B461E41CEQ46836622-A2B41DFF-DECF-4034-97FF-B29652C2F6EBQ46901630-7CBC81DB-6796-4596-9BB0-8297662F9AF6Q47309400-76020A8E-DAA4-4C84-82BC-02DCFA0319FAQ47915476-09F00ED5-5306-44EB-B435-C3F6D493BDE9Q48597834-50C1B556-1296-4A6D-8C31-E4F8AAABADA2Q58751451-793A838B-3956-4373-AD6F-718DDF9090FA
P2860
Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.
@ast
Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.
@en
type
label
Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.
@ast
Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.
@en
prefLabel
Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.
@ast
Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.
@en
P2093
P2860
P356
P1476
Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease
@en
P2093
J Williams
M A De Berardinis
M Combrinck
P2860
P356
10.1136/JNNP.2005.063131
P407
P577
2005-06-08T00:00:00Z